| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.21B | 51.14B | 49.30B | 47.60B | 46.88B | 44.13B |
| Gross Profit | 11.77B | 11.74B | 11.89B | 11.93B | 12.49B | 11.53B |
| EBITDA | 5.38B | 5.35B | 5.71B | 5.78B | 6.65B | 5.45B |
| Net Income | 3.36B | 3.05B | 3.55B | 3.54B | 4.17B | 3.41B |
Balance Sheet | ||||||
| Total Assets | 41.77B | 41.75B | 39.83B | 36.20B | 33.83B | 30.62B |
| Cash, Cash Equivalents and Short-Term Investments | 19.21B | 20.57B | 20.94B | 18.37B | 16.43B | 19.41B |
| Total Debt | 275.51M | 87.84M | 70.68M | 61.96M | 72.92M | 65.77M |
| Total Liabilities | 8.44B | 8.51B | 8.68B | 7.73B | 8.03B | 8.32B |
| Stockholders Equity | 31.99B | 31.89B | 30.04B | 27.61B | 25.11B | 21.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.23B | 3.72B | 3.25B | -2.24B | 4.08B |
| Operating Cash Flow | 0.00 | 4.37B | 4.49B | 3.55B | 4.03B | 4.20B |
| Investing Cash Flow | 0.00 | -3.33B | -712.00M | -337.99M | -6.10B | -122.14M |
| Financing Cash Flow | 0.00 | -1.42B | -1.24B | -1.31B | -870.93M | -901.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ¥246.22B | 16.33 | 28.98% | 5.57% | 4.09% | 17.10% | |
75 Outperform | ¥142.32B | 20.10 | ― | 2.38% | 20.17% | 32.32% | |
73 Outperform | ¥9.66T | 21.38 | 27.29% | 0.27% | 1.23% | 26.94% | |
69 Neutral | ¥30.14B | 10.06 | ― | 3.82% | 1.22% | -5.35% | |
66 Neutral | ¥542.85B | 15.57 | 19.18% | 3.59% | 6.95% | 13.63% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥73.79B | -1,275.30 | -6.02% | 0.77% | -9.70% | -108.59% |